What is the recommended management, including rehydration, antibiotic therapy, diagnostic testing, and follow‑up, for an adult with Campylobacter gastroenteritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is Campylobacter?

What is the treatment approach for campylobacter (Campylobacter) gastrointestinal (GI) infection?

What is the primary mode of transmission for Campylobacter species?

What is the appropriate initial management for a 17-year-old boy with vomiting, diarrhea, and dizziness, suspected of having a Campylobacter infection?

What is the likely cause of a patient's symptoms, including dark, possibly blood-tinged diarrhea, yellow foul-smelling diarrhea with varying consistency (Bristol stool chart type 4-6), indigestion, and nausea or acid reflux, with a normal Complete Blood Count (CBC) and a Gastrointestinal Polymerase Chain Reaction (Gastro PCR) positive for Campylobacter?

Can micafungin be used in patients with any degree of renal impairment, including those on hemodialysis, without dose adjustment?

Which surgeon should be consulted first for a patient with a sacral pressure ulcer complicated by sacral osteomyelitis?

What is the recommended initiation, dosing, monitoring, and contraindications for lactulose in an adult with elevated serum ammonia and suspected hepatic encephalopathy, and when should rifaximin be added?

In an adult with persistent central chest (sternal) pain, what are the recommended initial investigations and long‑term management?

In a patient with chronic kidney disease (any stage, including dialysis), how should caspofungin be dosed and monitored, and is any renal dose adjustment required?

What is the recommended surveillance for a 37‑year‑old woman with focal atypical endometrial hyperplasia after hysteroscopic polypectomy who is now using a levonorgestrel‑releasing intrauterine device (LNG‑IUD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.